Shattuck Labs (STTK) Equity Average (2019 - 2026)
Shattuck Labs (STTK) reported Equity Average of $89.1 million for Q1 2026, up 21.07% year-over-year from $73.6 million in Q1 2025, and up 1.48% quarter-over-quarter from $87.8 million in Q4 2025.
Shattuck Labs (STTK) Equity Average (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has 8 years of Equity Average data on file, last reported at $89.1 million in Q1 2026.
- Equity Average for Q1 2026 came in at $89.1 million, up 21.07% year-over-year; the trailing twelve-month figure through Mar 2026 was $89.1 million (up 21.07% YoY), and the FY2025 annual result was $81.0 million, down 27.78% from the prior year.
- Equity Average climbed to $89.1 million in Q1 2026 per STTK's latest filing, from $87.8 million in the prior quarter.
- Over five years, Equity Average peaked at $260.4 million in Q1 2022 and troughed at $62.3 million in Q2 2025.
- A 5-year average of $135.3 million and a median of $125.6 million in 2023 frame the typical range for Equity Average.
- The sharpest annual moves came in 2025 and 2026: Equity Average sank 47.96% in 2025, then gained 21.07% in 2026.
- A 5-year view of Equity Average shows it stood at $187.8 million in 2022, then plunged by 31.44% to $128.7 million in 2023, then tumbled by 31.57% to $88.1 million in 2024, then decreased by 0.33% to $87.8 million in 2025, then climbed by 1.48% to $89.1 million in 2026.
- Business Quant data shows STTK's Equity Average at $89.1 million in Q1 2026, $87.8 million in Q4 2025, and $75.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 3.50 Bn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 783.14 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.76 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.01 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 21.35 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.01 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 516.41 Mn |
| 10 | Shattuck Labs | 190.32 Mn | 190.32 Mn | - | 89.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 89.11 Mn |
| Dec 31, 2025 | 87.82 Mn |
| Sep 30, 2025 | 75.13 Mn |
| Jun 30, 2025 | 62.30 Mn |
| Mar 31, 2025 | 73.61 Mn |
| Dec 31, 2024 | 88.10 Mn |
| Sep 30, 2024 | 103.60 Mn |
| Jun 30, 2024 | 119.71 Mn |
| Mar 31, 2024 | 136.76 Mn |
| Dec 31, 2023 | 128.74 Mn |
| Sep 30, 2023 | 125.62 Mn |
| Jun 30, 2023 | 148.06 Mn |
| Mar 31, 2023 | 166.91 Mn |
| Dec 31, 2022 | 187.79 Mn |
| Sep 30, 2022 | 210.97 Mn |
| Jun 30, 2022 | 235.73 Mn |
| Mar 31, 2022 | 260.36 Mn |
| Dec 31, 2021 | 266.48 Mn |
| Sep 30, 2021 | 269.13 Mn |
| Jun 30, 2021 | 287.87 Mn |